Case File
efta-efta01814027DOJ Data Set 10CorrespondenceEFTA Document EFTA01814027
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01814027
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Jeffrey M Matusai
From:
Jeffrey Epstein
Sent
Thur 8/3/2010 12:46:30 AM
Subject Re: Update
I think we should see a HIGHER EURO< be careful.. lets look at closing the postion in both euro
and pound.
On Wed, Jun 2, 2010 at 6:05 PM, Jeffrey M Matusow
wrote:
Nice recovery in the market today. S+P rallied at the end of the day to close up 28 points (Dow up 225
pts)
Euro closed at the high - 1.2250. GBP holding its gains at 1.4650. JPY weaker at 92.20 on the
resignation of the PM.
The Dividends finished up a few points. 2011 at 97 and 2012 at 92. Goldman issued a report
recommending clients buy both 2011 and 2012 - they see limited downside from here, even under worst
case scenarios.
GS up S3 at S144.85. OIL closed marginally higher at $73.60
Swap rates higher on the rally in the equity markets.
I still think we should add to our Euro short. We are dipping our toes back into risk trades - buying
CAD, Selling 4% swaptions, buying BRL.
Call me tomm.
Jeff
Jeffrey M. Matusow
JPMorgan Private Bank 140 West 57th Street. 33rd Floor, New York. NY 10019
EFTA_R1_00184710
EFTA01814027
Work 212 822.70531 Fax 212 310 0108 i Ernz. jeffrev.m matusowniorroman.COM
IRS Circular 230 Disclosure.
JPP.iorgan Chase & Co and its affiliates do not provide tax advice. Accordingly. any discussion of U.S. tax matters contained herein
(including any attachments) is not intended or written to be used. and cannot be used. in connection with the promobon, marketing or
recommendation by anyone unaffiliated with JPMorgan Chase & Co of any of the matters addressed herein or for the purpose of
avoiding U.S. tax-related penalties.
This email is confidential and subject to important disclaimers and conditions including on
offers for the purchase or sale of securities, accuracy and completeness of information,
viruses, confidentiality, legal privilege, and legal entity disclaimers, available at
hun://www.ipmorgan.cornipagesidisclosurcslemail.
***********************************************
*A* A** in
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA_R1_00184711
EFTA01814028
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.